1999
DOI: 10.1046/j.1440-0960.1999.00345.x
|View full text |Cite
|
Sign up to set email alerts
|

Basal cell carcinoma of the scrotum

Abstract: An 80-year-old man with a 7 year history of a slowly enlarging, asymptomatic scrotal nodule is presented. He had a negative history for sexually transmitted disease, trauma to the area, radiotherapy and chemical or arsenic exposure. The lesion was excised with a margin of 0.8 cm of normal skin. Examination of the specimen revealed a basal cell carcinoma.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2000
2000
2024
2024

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(2 citation statements)
references
References 22 publications
0
2
0
Order By: Relevance
“…In contrast to non-genital BCCs, however, genital BCCs are extremely rare; their incidence in Western countries is less than 4% of all genital cancers and less than 1% of all BCCs (3). Although there is no significant difference between female and male patients regarding the incidence of non-genital BCCs (2), genital BCCs are predominantly reported in females and the incidence of vulvar lesions (4, 5) is nearly eight times higher than that of scrotal lesions (6)(7)(8). On the other hand, in Japan, a recent study by Fujita et al (9) found that the 35 cases of genital BCC reported in last 10 years revealed a three fold higher incidence in female patients than in males.…”
Section: Discussionmentioning
confidence: 99%
“…In contrast to non-genital BCCs, however, genital BCCs are extremely rare; their incidence in Western countries is less than 4% of all genital cancers and less than 1% of all BCCs (3). Although there is no significant difference between female and male patients regarding the incidence of non-genital BCCs (2), genital BCCs are predominantly reported in females and the incidence of vulvar lesions (4, 5) is nearly eight times higher than that of scrotal lesions (6)(7)(8). On the other hand, in Japan, a recent study by Fujita et al (9) found that the 35 cases of genital BCC reported in last 10 years revealed a three fold higher incidence in female patients than in males.…”
Section: Discussionmentioning
confidence: 99%
“…According to the risk of recurrence, BCC is classified into low-risk subtypes (nodular, superficial, pigmented, infundibulocystic, and fibroepithelial) and high-risk subtypes (infiltrating, micronodular, sclerosing/morphoeic, basosquamous, and BCC with sarcomatoid differentiation) [ 12 ]. The majority of reported scrotal BCCs are nodular, with only a minority of them being micronodular, infiltrating, and sclerosing/morphoeic [ 3 , 7 , 13 , 14 ].…”
Section: Introductionmentioning
confidence: 99%